APA citiranje

(22551717), L. N. S., (22551718), U. L. M., (422231), K. C., (22551719), T. S. H., (22551721), J. S. H., (22551727), S. J. C., . . . (22551735), K. A. P. (2025). <b>MODY is prevalent in later-onset diabetes, has potential for targeted therapy but is challenging to identify</b>.

Chicago Style (17th ed.) Citation

(22551717), Luke N Sharp, et al. <b>MODY Is Prevalent in Later-onset Diabetes, Has Potential for Targeted Therapy but Is Challenging to Identify</b>. 2025.

MLA citiranje

(22551717), Luke N Sharp, et al. <b>MODY Is Prevalent in Later-onset Diabetes, Has Potential for Targeted Therapy but Is Challenging to Identify</b>. 2025.